HOME
MORE ABOUT US
SCIENCE
CAREERS
CONTACT US
In addition to sepsis and renal impairment, Endacea believes that other indications for Endacea's proprietary A1 AR antagonists include allergic rhinitis, asthma, and chronic obstructive pulmonary disease.